Literature DB >> 17684146

Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer.

Yan Cui1, Stefan Vogt, Neal Olson, Andrew G Glass, Thomas E Rohan.   

Abstract

Previous studies that have assessed breast cancer in relation to zinc, selenium, calcium, and iron have yielded inconsistent results but have not measured breast tissue levels. In a case-control study involving 252 matched pairs nested in a cohort of 9,315 women with benign breast disease, we investigated these associations by directly measuring elemental levels in breast tissue using X-ray fluorescence spectroscopy. Quintile analyses revealed positive associations of breast cancer, of borderline statistical significance, with zinc [highest versus lowest quintile: odds ratio (OR), 1.37; 95% confidence limit (95% CL), 0.91, 2.05; P(trend) = 0.04], iron (highest versus lowest quintile: OR, 1.58; 95% CL, 1.02, 2.44; P(trend) = 0.07), and calcium (highest versus lowest quintile: OR, 1.46; 95% CL, 0.98, 2.17; P(trend) = 0.14), but little association with selenium (highest versus lowest quintile: OR, 1.10; 95% CL, 0.72, 1.68; P(trend) = 0.76). The associations were weakened by mutual adjustment. Furthermore, after stratification by menopausal status, the positive association between iron and breast cancer was confined to postmenopausal women (highest versus lowest quintile: OR, 2.77; 95% CL, 1.25, 6.13; P(trend) = 0.008), whereas the associations for zinc, calcium, and selenium did not differ by menopausal stratum. In conclusion, our data raise the possibility that relatively high levels of zinc, iron, and calcium in benign breast tissue may be associated with a modest increase in risk of subsequent breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684146     DOI: 10.1158/1055-9965.EPI-07-0187

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  32 in total

Review 1.  Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.

Authors:  Shannon L Kelleher; Nicholas H McCormick; Vanessa Velasquez; Veronica Lopez
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

Review 2.  Selenium for preventing cancer.

Authors:  Marco Vinceti; Gabriele Dennert; Catherine M Crespi; Marcel Zwahlen; Maree Brinkman; Maurice P A Zeegers; Markus Horneber; Roberto D'Amico; Cinzia Del Giovane
Journal:  Cochrane Database Syst Rev       Date:  2014-03-30

3.  Mammary gland zinc metabolism: regulation and dysregulation.

Authors:  Shannon L Kelleher; Young Ah Seo; Veronica Lopez
Journal:  Genes Nutr       Date:  2009-04-02       Impact factor: 5.523

Review 4.  Selenium for preventing cancer.

Authors:  Gabriele Dennert; Marcel Zwahlen; Maree Brinkman; Marco Vinceti; Maurice P A Zeegers; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

5.  Exome Sequencing of SLC30A2 Identifies Novel Loss- and Gain-of-Function Variants Associated with Breast Cell Dysfunction.

Authors:  Samina Alam; Stephen R Hennigar; Carla Gallagher; David I Soybel; Shannon L Kelleher
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-08-21       Impact factor: 2.673

6.  Functional analysis of two single nucleotide polymorphisms in SLC30A2 (ZnT2): implications for mammary gland function and breast disease in women.

Authors:  Young Ah Seo; Shannon L Kelleher
Journal:  Physiol Genomics       Date:  2010-09-21       Impact factor: 3.107

7.  Zinc distribution within breast cancer tissue: A possible marker for histological grading?

Authors:  David Riesop; Alfred V Hirner; Peter Rusch; Agnes Bankfalvi
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-12       Impact factor: 4.553

8.  Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai.

Authors:  Amber B Moore; Jackilen Shannon; Chu Chen; Johanna W Lampe; Roberta M Ray; Sharon K Lewis; Minggang Lin; Helge Stalsberg; David B Thomas
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

9.  In situ clinical evidence that zinc levels are decreased in breast invasive ductal carcinoma.

Authors:  Leslie C Costello; Jing Zou; Renty B Franklin
Journal:  Cancer Causes Control       Date:  2016-04-20       Impact factor: 2.506

10.  Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7.

Authors:  Hui Shen; Haihong Qin; Junsheng Guo
Journal:  Mol Biol Rep       Date:  2008-03-11       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.